Wang et al. advanced this concept using peptide-based supermolecular silk hydrogels co-delivering anti-PD1 antibodies, IL-15, and STING agonists, achieving tumor regression and overcoming monotherapy resistance [18]. The gene discussed is IL15; the disease is neoplasm.